Ownership history in Prostatis Group LLC Β· 7 quarters on record
This page tracks every 13F SEC filing in which Prostatis Group LLC reported a position in VANGUARD INDEX FDS (VUG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Prostatis Group LLC outperformed the S&P 500 by +12.8% annually on this VUG position. Timing score: 50% (3/6 decisions correct). Average cost basis: $294.69. Maximum drawdown during holding period: β9.5%.
π₯ Exceptional β beat the S&P 500 by 12.8% per year on this position.
6 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
3 of 6 add/trim decisions correct
Best entry: $245.90 (2023 Q1) Β· Worst: $487.86 (2025 Q4)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
3 adds Β· 4 trims. Bought during 1 of 1 down-price quarters. π Predominantly trimming β distribution phase.
π Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 3.04% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size